GWN Securities Inc. Takes Position in The Cigna Group (NYSE:CI)

GWN Securities Inc. purchased a new position in shares of The Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 794 shares of the health services provider's stock, valued at approximately $233,000.

Other large investors have also bought and sold shares of the company. Collier Financial bought a new position in shares of The Cigna Group during the fourth quarter valued at about $32,000. ORG Wealth Partners LLC purchased a new position in The Cigna Group during the 4th quarter valued at about $34,000. Prospera Private Wealth LLC bought a new position in The Cigna Group during the 3rd quarter valued at approximately $37,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group in the 4th quarter worth approximately $37,000. Finally, Heck Capital Advisors LLC bought a new stake in shares of The Cigna Group in the 4th quarter worth approximately $53,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Stock Down 1.4 %

Shares of CI traded down $4.61 during trading hours on Friday, hitting $316.78. The company had a trading volume of 3,552,779 shares, compared to its average volume of 1,564,478. The stock has a market capitalization of $86.70 billion, a price-to-earnings ratio of 25.88, a P/E/G ratio of 0.98 and a beta of 0.53. The firm has a fifty day moving average price of $300.07 and a 200-day moving average price of $315.72. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the previous year, the firm earned $6.79 earnings per share. On average, equities research analysts forecast that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.91%. This is an increase from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group's dividend payout ratio (DPR) is currently 49.35%.

Insiders Place Their Bets

In other news, Director Elder Granger sold 2,376 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total transaction of $737,391.60. Following the sale, the director now owns 5,471 shares of the company's stock, valued at $1,697,924.85. This trade represents a 30.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Noelle K. Eder sold 9,944 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares of the company's stock, valued at $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,751 shares of company stock valued at $13,603,991. Corporate insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Oppenheimer dropped their price target on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a research note on Friday, January 31st. Stephens cut their target price on shares of The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Cantor Fitzgerald boosted their price target on shares of The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research report on Thursday. Wells Fargo & Company lowered their price objective on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a report on Tuesday, February 4th. Finally, Royal Bank of Canada set a $355.00 target price on The Cigna Group in a report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $373.25.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.